To stop Alzheimer’s disease, a leading theory proposes reducing in-brain buildup of a protein fragment known as beta-amyloid. Scientists struggling to achieve this goal are, for example, testing a vaccine that prompts the immune system to clear this amyloid from the brain.
The solution may be even simpler. A study in mice suggests that ibuprofen, the common nonprescription drug, may lessen abnormal accumulation of beta-amyloid.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.